Wound treatment developer Tissium has raised €38.75m (US$42.8m) Series B funding to support the company’s expansion globally, particularly in the fields of nerve repair, cardiovascular and gastroenterology treatments. Funds will…
Wound treatment developer Tissium has raised €38.75m (US$42.8m) Series B funding to support the company’s expansion globally, particularly in the fields of nerve repair, cardiovascular and gastroenterology treatments. Funds will…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference